Elderly patients face greater perioperative risks and postoperative mortality, so careful selection of surgical candidates is imperative.
A recent study found that only 12% of patients older than 80 years received radical treatment for invasive disease.
A pathologist was unable to determine if a bladder tumor was muscle invasive because biopsy samples did not include muscle tissue.
New findings identify STAG2 as one of the most commonly mutated genes in bladder cancer, particularly in tumors that do not metastasize.
More than half of all venous thromboembolism events were diagnosed after patient discharge.
Study suggests benefit of adding of emetine dihydrochloride to treatment.
Increased risk in first year after diagnosis limited to those with fewest doc visits in previous two years.
Compared with whites, Hispanics had an 88% increased odds of major post-cystectomy complications.
A device containing a sensor can indicate in approximately 30 minutes whether cancer cells are present in the bladder.
Risk of post-operative problems is linked to urinary diversion type.
Women in the highest quartile of total fruit and vegetable consumption had a 65% decreased risk compared with those in the lowest quartile.
These factors plus pathologic findings enable stratification of patients according to their risk of dying from bladder cancer after radical cystectomy.
Intravesical chemotherapy right after transurethral resection of bladder tumor prolonged the recurrence-free interval by 38%.
Routine screening for bladder cancer may be warranted in this patient population.
Increased prophylaxis may benefit patients with non-O blood type.
Lower urinary tract symptoms alone should raise suspicion for the malignancy.
Compared with non-smokers, heavy smokers had a 38% increased risk of having muscle-invasive disease at presentation.
A large observational study showed that cannabis users had a 45% decreased risk of developing the malignancy.